Khảo sát giá trị EQ-5D-5L của Na Uy cho các trạng thái sức khỏe giả thuyết và dựa trên kinh nghiệm dựa trên giao thức Công nghệ Định giá EuroQol (EQ-VT)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hagen, 2013, Helseøkonomisk evaluering ved Nasjonalt kunnskapssenter for helsetjenesten, Nor Epidemiol, 23, 157
Statens Legemiddelverk (National Medicine Agency) . Guidelines for the submission of documentation for single technology assessment (STA) of pharmaceuticals, 2018.
Ottersen, 2016, A new proposal for priority setting in Norway: open and fair, Health Policy, 120, 246, 10.1016/j.healthpol.2016.01.012
På ramme alvor: alvorlighet og prioritering . Report from Working group appointed by Norwegian Ministry of health and care services; 2015.
Norwegian Ministry of Health and Care Services . Principles for priority setting in health care— summary of a white paper on priority setting in the Norwegian health care sector; 2015.
Drummond MF SM , Torrance G , O'Brien B , et al . Methods for the economic evaluation of health care programmes. 3rd edn. Oxford University Press, 2005.
Devlin, 2017, EQ-5D and the EuroQol group: past, present and future, Appl Health Econ Health Policy, 15, 127, 10.1007/s40258-017-0310-5
Nord E . Cost-Value analysis in health care: making sense out of QALYS. Cambridge University Press, 1999.
EuroQol . EQ-5D-5L | Self-complete version on paper. Available: https://euroqol.org/eq-5d-instruments/eq-5d-5l-available-modes-of-administration/self-complete-on-paper/
EuroQol . Sample UK English EQ-5D-5L paper Self-complete version.
Szende A OM , Devlin N , eds. EQ-5D Value Sets: Inventory, Comparative Review and User Guide. Dordrecht, The Netherlands: Springer, 2007.
Devlin, 2018, Valuing health-related quality of life: an EQ-5D-5L value set for England, Health Econ, 27, 7, 10.1002/hec.3564
Ludwig, 2018, German value set for the EQ-5D-5L, Pharmacoeconomics, 36, 663, 10.1007/s40273-018-0615-8
Augustovski, 2016, An EQ-5D-5L value set based on Uruguayan population preferences, Qual Life Res, 25, 323, 10.1007/s11136-015-1086-4
Hobbins, 2018, Utility values for health states in Ireland: a value set for the EQ-5D-5L, Pharmacoeconomics, 36, 1345, 10.1007/s40273-018-0690-x
Kim, 2016, The EQ-5D-5L valuation study in Korea, Qual Life Res, 25, 1845, 10.1007/s11136-015-1205-2
Luo, 2017, Estimating an EQ-5D-5L value set for China, Value Health, 20, 662, 10.1016/j.jval.2016.11.016
M Versteegh, 2016, Dutch tariff for the five-level version of EQ-5D, Value Health, 19, 343, 10.1016/j.jval.2016.01.003
Pattanaphesaj, 2018, The EQ-5D-5L valuation study in Thailand, Expert Rev Pharmacoecon Outcomes Res, 18, 551, 10.1080/14737167.2018.1494574
Purba, 2017, The Indonesian EQ-5D-5L value set, Pharmacoeconomics, 35, 1153, 10.1007/s40273-017-0538-9
Shafie, 2019, EQ-5D-5L valuation for the Malaysian population, Pharmacoeconomics, 37, 715, 10.1007/s40273-018-0758-7
Wong, 2018, Assessing the use of a feedback module to model EQ-5D-5L health states values in Hong Kong, Patient, 11, 235, 10.1007/s40271-017-0278-0
Nilsson, 2016, Patient-reported outcomes in the Swedish national quality registers, J Intern Med, 279, 141, 10.1111/joim.12409
Hernández-Alava M , Pudney S , Wailoo A . Quality review of a proposed EQ-5D-5L value set for England. Policy Research Unit in Economic Evaluation of Health and Care Interventions. Universities of Sheffield and York: EEPRU Research, 2018.
National Institute for Health and Care Excellence . Position statement on use of the EQ-5D-5L valuation set for England (updated November 2019), 2019. Available: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l
Kularatna, 2017, Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L value sets, Value Health Reg Issues, 12, 20, 10.1016/j.vhri.2017.01.001
Golicki, 2014, Interim EQ-5D-5L value set for Poland: first Crosswalk value set in central and eastern Europe, Value Health Reg Issues, 4, 19, 10.1016/j.vhri.2014.06.001
Olsen, 2018, In search of a common currency: a comparison of seven EQ-5D-5L value sets, Health Econ, 27, 39, 10.1002/hec.3606
Leidl, 2017, An experience-based value set for the EQ-5D-5L in Germany, Value Health, 20, 1150, 10.1016/j.jval.2017.04.019
Sun, 2015, Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China, Qual Life Res, 24, 693, 10.1007/s11136-014-0793-6
NICE . Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence, 2008.
Dolan, 2011, Thinking about it: thoughts about health and valuing QALYs, Health Econ, 20, 1407, 10.1002/hec.1679
TLV . Stivarga kommer inte att ingå i högkostnadsskyddet. [Stivarga will not be reimbursed]. Stockholm: TLV, 2014.
Dolan, 2009, NICE should value real experiences over hypothetical opinions, Nature, 462, 10.1038/462035a
Heijink, 2017, International comparison of experience-based health state values at the population level, Health Qual Life Outcomes, 15, 10.1186/s12955-017-0694-9
Dolan, 2008, Interpretations of utility and their implications for the valuation of health, Econ J, 118, 215, 10.1111/j.1468-0297.2007.02110.x
Cubi-Molla, 2018, Experience-Based values: a framework for classifying different types of experience in health valuation research, Patient, 11, 253, 10.1007/s40271-017-0292-2
Oppe, 2014, A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol, Value Health, 17, 445, 10.1016/j.jval.2014.04.002
Oppe, 2016, EuroQol protocols for time trade-off valuation of health outcomes, Pharmacoeconomics, 34, 993, 10.1007/s40273-016-0404-1
Microdata.no , 2019. Available: https://microdata.no/en/
Purba, 2017, Employing quality control and feedback to the EQ-5D-5L valuation protocol to improve the quality of data collection, Qual Life Res, 26, 1197, 10.1007/s11136-016-1445-9
Ramos-Goñi, 2017, Quality control process for EQ-5D-5L valuation studies, Value Health, 20, 466, 10.1016/j.jval.2016.10.012
Stolk, 2019, Overview, update, and lessons learned from the International EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol, Value Health, 22, 23, 10.1016/j.jval.2018.05.010
van Nooten, 2018, What should we know about the person behind a TTO?, Eur J Health Econ, 19, 1207, 10.1007/s10198-018-0975-1
van Nooten, 2015, "Married with children" the influence of significant others in TTO exercises, Health Qual Life Outcomes, 13, 10.1186/s12955-015-0276-7